(CIDRAP News) Cost issues and the risk of viral resistance drew considerable attention today in an online presentation by federal health officials on their revised guidance regarding use of antiviral drugs in an influenza pandemic.
The Department of Health and Human Services (HHS) released two guidance documents this week, one on antiviral use in general and one on employer stockpiling of antivirals.
(CIDRAP News) – A new report from the University of Minnesota warns that an influenza pandemic could disrupt the coal industry, thereby endangering the nation's significantly coal-dependent electric power system and everything that depends on it.
(CIDRAP News) The US Department of Health and Human Services (HHS) today hosted an online conversation among experts, government officials, and members of the public that touched on emerging issues in pandemic planning, such as anticipating supply chain interruptions and keeping the momentum going during tough economic times.
(CIDRAP News) The World Health Organization (WHO) has drafted a revised pandemic influenza preparedness plan that updates the definitions of pandemic phases and puts more emphasis on the social and economic effects of a global epidemic, among other changes.
(CIDRAP News) An internal report prepared by the World Bank estimates that a severe influenza pandemic could kill 71 million people and cause a recession costing more than $3 trillion, Bloomberg News reported today.
The report says that in a severe pandemic, sagging tourism, transportation, retail sales, and productivity, coupled with worker absenteeism, could reduce global gross domestic product (GDP) by 4.8%, according to Bloomberg.
(CIDRAP News) State pandemic preparedness has improved over the past few years, but gaps remain, particularly in areas that don't relate directly to healthcare such as continuing government operations, maintaining essential services, and coordinating with the private sector, according to a recent report from the National Governors Association (NGA).
(CIDRAP News) The current financial crisis may be pulling time and resources away from business pandemic planning, but two experts on the topic today told corporate leaders they can improve their firms' survivability during a global health emergency by avoiding specific mistakes.
(CIDRAP News) – A flu vaccine manufacturer's decision not to build a US facility has highlighted the perpetual mismatch between flu-shot supply and demand—and the reality that the mismatch may undermine plans for pandemic flu vaccines.
(CIDRAP News) GlaxoSmithKline, maker of the antiviral drug zanamivir (Relenza), today launched a program designed to help businesses stockpile the drug as a strategy to protect employees in the event of an influenza pandemic.